Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
VVN461 Ophthalmic Solution in Noninfectious Anterior Uveitis (Phase II, China)
CTR20233037Phase 2Completed
- Sponsor
- Vimicro
- Start
- Sep 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of VVN461 in non-infectious anterior uveitis, sponsored by Vimicro. Started Sep 2023; status: completed.
02
Drugs
VVN461
03
Conditions
non-infectious anterior uveitis
Beyond the preview
Go deeper on CTR20233037.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20233037.